Dermata Therapeutics, Inc. (DRMA) Operating income 2020–2025
Dermata Therapeutics, Inc. (DRMA) annual operating income history from SEC filings — each fiscal year as reported.
-$7.8MFY2025 · since FY2020: -$3.2M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | +37.9% |
| FY2024 | -$12.5M | -55.6% |
| FY2023 | -$8.0M | +16.9% |
| FY2022 | -$9.7M | -23.1% |
| FY2021 | -$7.9M | -147.6% |
| FY2020 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice